Você esta aqui:Home > Cannabinoids (antigo) > Letter: Preclinical assessment of abuse liability of ajulemic acid
Cannabinoids 2007;2(1):3-4 (21 January 2007)
Letter to the Editor
Letter: Preclinical assessment of abuse liability of ajulemic acid
Jenny L. Wiley
Department of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, VA, USA, jwiley@vcu.edu
No abstract available.
Eventos Online 2020
Todas as informações sobre os Eventos IACM Online, incluindo vídeos gratuitos dos webinars com legendas em português, podem ser encontradas aqui.
Conferência 2022
A 12ª Conferência IACM sobre Canabinóides em Medicina será realizada nos dias 20 e 21 de Outubro de 2022 juntamente com o SSCM suíço em Basileia/Suíça.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.